Gentamicin
Gentamicin
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
Once daily dose: 5–7 mg/kg, dose is then adjusted according to levelsEndocarditis: 1 mg/kg every 8 hours Intrathecal: 1–5 mg daily PD peritonitis: see local policy
PHARMACOKINETICS
Molecular weight                           :477.6 %Protein binding                           :0–30 %Excreted unchanged in urine     : 90 Volume of distribution (L/kg)       :0.3half-life – normal/ESRD (hrs)      :2–3/20 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
30–70 3–5 mg/kg daily and monitor levels10–30 2–3 mg/kg daily and monitor levels5–10 2 mg/kg every 48–72 hours according to levels DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Dialysed. CAPD                : clearance is about 3 mL/min. Dose as in GFR=5–10 mL/min. Monitor levels HD                     :Dialysed. Dose as in GFR=5–10 mL/min. Give after dialysisHDF/high flux   :Dialysed. Dose as in GFR=5–10 mL/min. Give after dialysisCAV/VVHD      :Dialysed. Dose in GFR= 30–70 mL/min according to severity of infection, and measure levels IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsBotulinum toxin: neuromuscular block enhanced – risk of toxicityCiclosporin: increased risk of nephrotoxicityCytotoxics: increased risk of nephrotoxicity and possibly of ototoxicity with platinum compounds Diuretics: increased risk of ototoxicity with loop diureticsMuscle relaxants: effects of non- depolarising muscle relaxants and suxamethonium enhancedParasympathomimetics: antagonism of effect of neostigmine and pyridostigmine Tacrolimus: increased risk of nephrotoxicity ADMINISTRATION
Reconstition
– Route
IV, IM, IP, intrathecal Rate of Administration
Bolus IV: over not less than 3 minutes Short infusion: 20–30 minutes Once daily large infusions over 30– 60 minutesComments
Can be added to sodium chloride or glucose 5% OTHER INFORMATION
Concurrent penicillins may result in sub- therapeutic blood levelsMonitor blood levels. 1 hour post-dose peak levels must not exceed 10 mg/L. Pre-dose trough levels should be less than 2 mg/LIP therapy commonly used for PD peritonitis. Dose varies according to local protocol and whether CAPD                : or APD dialysis. Monitoring of blood levels is advisable, as absorption is increased by inflamed peritoneumPotential nephrotoxicity of the drug may worsen residual renal functionLong-term concurrent use of gentamicin with teicoplanin causes additive ototoxicity.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home